← back to search

Xiaoli Li

University of Alabama at Birmingham · US
Area of research
Analytical Chemistry · Biomedical Engineering
Research interest
Research focused on Overweight and Cultivar, with related work in Cell biology, Neural crest, Enantioselective synthesis. Notable publications include 'A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity', 'Cross-cultivar prediction of quality indicators of tea based on VIS-NIR hyperspectral imaging', and 'The Unique Cytoplasmic Domain of Human FcγRIIIA Regulates Receptor-Mediated Function'.
h-index
citations
193
works
8
NIH funding
primary concept
email

Recent publications

Novel herbicide flusulfinam: absolute configuration, enantioseparation, enantioselective bioactivity, toxicity and degradation in paddy soils
Pest Management Science 2024cited by 11position: middledoi
Deep Learning-Based Detection of Impacted Teeth on Panoramic Radiographs
Biomedical Engineering and Computational Biology 2024cited by 7position: lastdoi
Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators
Gynecological Endocrinology 2024cited by 5position: firstdoi
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
Nature Communications 2023cited by 90position: middledoi
Cross-cultivar prediction of quality indicators of tea based on VIS-NIR hyperspectral imaging
Industrial Crops and Products 2023cited by 31position: lastdoi
miRNA-21-5p is an important contributor to the promotion of injured peripheral nerve regeneration using hypoxia-pretreated bone marrow–derived neural crest cells
Neural Regeneration Research 2023cited by 15position: middledoi
Enhancing Anticancer Efficacy of Formononetin Microspheres via Microfluidic Fabrication
AAPS PharmSciTech 2023cited by 9position: middledoi
Erlotinib Plus Capecitabine as First-Line Treatment for Older Chinese Patients With Advanced Adenocarcinoma of the Lung (C-TONG0807)
Medicine 2015cited by 2position: middledoi
The Unique Cytoplasmic Domain of Human FcγRIIIA Regulates Receptor-Mediated Function
The Journal of Immunology 2012cited by 28position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Li Zhang · Nanchang University1 papers (2015–2015)Liming Chen · Fujian University of Traditional Chinese Medicine1 papers (2023–2023)Kai Liu · Jiangsu University1 papers (2023–2023)Liting Wang · Nantong University1 papers (2023–2023)Qilong Wang · Shenyang Pharmaceutical University1 papers (2023–2023)Yipeng Wang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2024–2024)Meiqi Shi · Chinese PLA General Hospital1 papers (2015–2015)Li Yan · Air Force Medical University1 papers (2023–2023)Jifeng Feng · Zhejiang Cancer Hospital1 papers (2015–2015)Tao Yang · Tang Du Hospital1 papers (2023–2023)Yiping Zhang · Sun Yat-sen University Cancer Center1 papers (2015–2015)Lixia Ma · Ningbo University1 papers (2015–2015)Hong-Yun Zhao · Sun Yat-sen University1 papers (2015–2015)Cong Meng · Nantong University1 papers (2023–2023)Lian Lei · Kunming University of Science and Technology1 papers (2024–2024)Xia Wu · Nantong University1 papers (2023–2023)Qintong Yu · Jiangsu University1 papers (2023–2023)Ling-jie Zhu · Nantong University1 papers (2023–2023) · 1 papers (2023–2023)Jiangnan Yu · The First Affiliated Hospital, Sun Yat-sen University1 papers (2023–2023)